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C-terminal Src kinase (Csk) [1] is a key negative regulator of Src-
family kinases (SFK), enzymes associated mostly with membrane
rafts. Csk phosporylates tyrosine residues located in the C-terminal
tails of Src-family kinases such as Lck [2] which promotes their
inhibited (closed) conformation and thus suppresses signaling by
various surface receptors, including T-cell receptor (TCR). The
inhibitory phosphotyrosine is dephosphorylated by transmembrane
phosphatases, most prominently by CD45 [3]. Thus, the proper level of
activity of SFK is set by the balance between these two key regulators.
While CD45 is a transmembrane protein, most of Csk is localized in
the cytoplasm and is recruited to its plasma membrane substrates
(SFK) via membrane-associated adaptor proteins. The inhibitory
activity of Csk on TCR signaling can be markedly reduced by a
mutation (R107K) abrogating the functionality of Csk SH2 domain
which is essential for Csk interaction with the membrane-associated
adaptor proteins. Fusion of Csk to the myristoylation membrane
targeting signal from c-Src was reported to restore the ability of the
R107K mutant to inhibit TCR-triggered signals, conﬁrming that Csk
recruitment to the plasma membrane is crucial for its function [4].
In T lymphocytes, a signiﬁcant fraction of SFK is found in membrane
rafts. Two of the membrane raft resident proteins, Phosphoproteinassociated with glycolipid-enriched microdomains (PAG) and Lck-
interacting membrane protein (LIME), interact with Csk and thus
contribute to negative regulation of SFK in this critical compartment
[5–8]. However, lymphocytes from PAG and LIME knock-outmice do not
show any apparent dysregulation of TCR signaling which would be
expected due to the reduced levels of membrane-associated Csk [9–11].
This either indicates that there are additional adaptors bringing Csk to
membrane rafts [12–15], or, alternatively, it may also suggest that
membrane raft-associated fraction of SFK is not critically important in
TCR signal transduction since a signiﬁcant pool of SFKs can be found
outside membrane rafts [16]. Moreover, a study where Src-homology 2
containing phosphatase 1 (SHP-1) was targeted to lipid rafts via a Linker
for activation of T cells (LAT)-anchoring sequence showed strong
inhibition of LAT phosphorylation and other events in TCR signaling
cascade by this construct, but the proximal phases including SFK
dependent ITAM phosphorylation and zeta-associated protein of
70 kDa (ZAP-70) activation were unaffected, again casting doubt over
the importance of lipid raft pool of SFK [17]. In line with these data also
seemed to be the observation that the effects of Csk SH2 domain
inactivation can be reversed by themembrane targeting of this construct
via c-Src myristoylation sequence [4]. The myristoylation signal from c-
Src is not generally believed to target proteins to membrane rafts and
thus this observation indicates that perhaps targeting of Csk to these
microdomains (as brought about by PAG/LIME) is not necessary for the
regulation of the pool of SFK involved in TCR signaling. However, it is also
possible that the Src targeting signal allows formembrane raft access, but
due to its speciﬁc nature and/or lackof palmitoylation its associationwith
membrane rafts may be more transient and difﬁcult to detect by
biochemical approaches.
Recently, we described a new type of raft-like microdomains
producing upon detergent solubilization “heavy DRMs“ (“heavy
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called here for the sake of simplicity (albeit somewhat imprecisely)
“heavy rafts“, contain a number of membrane molecules, appear to be
similar to the “classical rafts“ in yielding large (as judged by Sepharose
4B gel ﬁltration) DRMs resistant to solubilization by polyoxyethylene
type detergents, such as Brij-98, but sensitive to laurylmaltoside and to
cholesterol extraction. In contrast to classical raft-derived DRMs, the
heavy DRMs do not ﬂotate in density gradient and are more dependent
on protein-protein interactions[19]. Targeting of a key T cell signaling
molecule, transmembrane adaptor protein LAT, to heavy rafts rescued
TCR signaling in LAT deﬁcient cell line, albeit less effectively than
targeting into “classical“ rafts (where LAT is normally present). This
explained a previous puzzling result [20] indicating that targeting of
LAT to membrane rafts is actually not as essential as originally thought
[21,22].
In fact, there is very little direct functional evidence for the
importance of membrane raft targeting of signaling molecules such
as SFK or transmembrane adaptor proteins. As far as we are aware,
there is only a single report demonstrating the importance of
palmitoylation-based Lymphocyte-speciﬁc protein tyrosine kinase
(Lck) targeting into T cell membrane rafts not only for proper plasma
membrane localization but also for full signaling efﬁciency [23].
Therefore, it was of interest to compare functional effects of
targeting of Csk into classical membrane rafts, newly described heavy
rafts and non-raft membrane. The results should identify the plasma
membrane compartment(s) in which resides the fraction of endog-
enous SFKs responsible for the initiation of TCR signaling. This
approach is complementary to the one used by Kabouridis et al. [23]
based on Lck mutant transfectants.
To achieve this we constitutively targeted Csk to the Jurkat T cell
membrane by joining Csk with various membrane-targeting motifs.
Our data show that signaling through TCR can be completely inhibited
by several Csk constructs containing raft targeting motifs but not by
constructs targeted to non-raft membrane or to heavy raft-like
microdomains. The results further conﬁrm marked functional differ-
ence between the classical and heavy rafts and support the concept of
essential importance of membrane rafts in initiation of TCR signaling.
2. Materials and methods
2.1. DNA cloning, cells and antibodies
Human Csk cDNA was mutated via fusion PCR to introduce E154A,
W47A, R107K mutations and ligated at the C-terminus with Orange
ﬂuorescent protein (OFP) [24] using Myc-tag as a spacer, all these
constructs were subsequently cloned into pMXs retroviral vector
(kindly provided by Dr. A. Cerwenka, DKFZ, Heidelberg, Germany)
[25] via BamHI–SalI. Next, we inserted various transmembrane
domains (see Fig. 1A for details) at the N-terminal part of Csk-OFP
via BamHI. All constructs were veriﬁed by DNA sequencing. To
prepare inducibly targeted Csk molecules, we obtained all necessary
reagents from Ariad Pharmaceuticals (Cambridge, MA; www.ariad.
com/regulationkits). LAT TM domain sequence was joined with FRB
domain, we used FLAG Tag as a spacer to ensure ﬂexibility of the FRB
domain and the construct was cloned into pMSCV vector expressing
Thy1 as a surrogate marker from an IRES sequence placed down-
stream. Next, Csk-OFP was joined with a tandem FKBP domain and
cloned into pMXs retroviral vector, the FKBP domain was placed
downstream of the Csk-OFP and was separated via 8×Gly linker.
All constructs were veriﬁed by DNA sequencing. Jurkat cells were
from ATCC, and rabbit antiserum to human LAT was kindly provided
by Dr. L. Samelson (NIH, Bethesda, MD), rabbit antiserum to human
Lck by Dr. A. Veillette (Clinical Research Institute of Montreal,
Montreal, Canada), and mAb C305 to Jurkat cell TCR by Dr. A.Weiss
(UCSF, San Francisco, CA). Antibodies to CD69 (FITC-labeled; BD
Biosciences, San Jose, CA), CD25 and Thy1 (FITC and APC labeled;eBioscience, San Diego, CA), Phosphotyrosine (4 G10) (Millipore,
Billerica, MA), phospho-Lck Tyr505, phospho-Src-family Tyr416 and
Myc-tag (Cell Signaling Technology, Danvers, MA) and mouse anti-
Lck (Exbio, Prague, Czech Republic) were obtained from the indicated
commercial sources. To visualize proteins by Odyssey infra-red
scanner (Li-Cor Biosciences, Lincoln, NE), we detected primary
antibodies with goat anti-mouse, or goat-anti rabbit secondary
antibodies labeled with IR680 or IR800 dyes (Li-Cor Biosciences).
2.2. Retroviral infection and FACS sorting
Retroviruses (RV) were prepared by transfection of Phoenix-
Ampho cells (Origene, Rockville, MD) with plasmid DNA using
Lipofectamine (Invitrogen, Karlsbad, CA) in six-well plates. RV-
containing supernatant was centrifuged to remove debris and then
used to spin-infect (1200×g/90 min at room temperature) Jurkat cells
in the presence of Polybrene (10 μg/ml, Sigma-Aldrich, St. Loius, MO).
Cells were allowed to expand in culture and then were sorted using
FCAS Vantage cell sorter (BD Biosciences, San Jose, CA) to isolate
infected OFP+ cells.
2.3. Analysis of phosphorylated proteins
Cells (5×107/ml) were stimulated with C305 Ab (5 μg/ml) at
37 °C, at each time point, 0.1 ml of cell suspension were mixed with
equal volume of 2× sample buffer, sonicated and further denatured
for 3 min at 95 °C. Phosphorylated proteins were resolved by SDS-
PAGE and detected with mouse anti-phosphotyrosine (4G10). To
measure the levels of src-family tyrosine 416 and 505 phosphoryla-
tion, the lysates were immunoblotted with rabbit anti-phospho-Lck
Tyr505, rabbit anti-phospho-Src family Tyr416 and mouse anti-Lck
antibodies. The AP21967 treatment was carried out so that cells
(5×107/ml) were incubated for indicated time with 0.5 μM AP21967
and then lysed immediately in SDS sample buffer. In the casewhenwe
used infrared ﬂuorescence detection using Odyssey scanner, we
stained the membrane with mouse anti-Lck Ab and rabbit anti-pY416
or, anti-pY505 antibodies followed by goat anti-mouse IR680 and
goat-anti rabbit IR800 secondary antibodies. To quantify signal
intensities we exported the intensity values from the Odyssey
software and further processed those using Microsoft Excel software
(Microsoft, Redmond, WA) to generate the values of phospho-speciﬁc
signal normalized to total Lck.
2.4. DRM isolation, immunoblotting
To isolate DRM by gel ﬁltration, cells were ﬁrst fractionated to
purify cellular membranes. Cells (108) were resuspended in 0.4 ml of
ice-cold hypotonic buffer (10 mM HEPES pH 7.4, 42 mM KCl, 5 mM
MgCl2, protease inhibitor mixture), incubated on ice for 15 min and
then passed 10× through the 30-gauge needle. The suspension was
centrifuged 5 min at 300×g, 2 °C to remove nuclei. The ice-cold post-
nuclear supernatant was centrifuged 10 min at 25,000×g and 2 °C to
sediment the membranes. Membranes were then lysed in 0.2 ml 1%
Brij-98-containing lysis buffer (polyoxyethylene 20 oleyl ether;
Sigma-Aldrich, St. Louis, MO) for 30 min on ice, and spun at
10,000×g for 3 min, and 0.1 ml of the lysate was applied at the top
of a 1 ml Sepharose 4B column and sequentially washedwith 0.1 ml of
the lysis buffer; 0.1 ml fractions were collected (all performed at 4 °C)
and analyzed by SDS-PAGE/immunoblotting. To isolate DRM by
density gradient ultracentrifugation, cells (5×107) were solubilized
in 0.5 ml of the lysis buffer containing 1% Brij-98 (30 min on ice), then
0.5 ml of ice-cold 80% (wt/vol) sucrose in lysis buffer was added, and
placed at the bottom of a 5.2 ml polyallomer centrifuge tube
(Beckman Instruments) and carefully overlaid with 1.8 ml of 30%,
0.8 ml 20%, 0.8 ml 10% and 0.7 ml 5% sucrose in lysis buffer (with the
detergent) and ﬁnally with 0.1 ml of lysis buffer without sucrose.
Fig. 1. Constructs scheme and subcellular localization of Csk-OFP constructs. A: The Abbreviations: PM, plasma membrane; OFP, orange ﬂuorescent protein; the numbers in the
constructs denote the respective amino acid segments. zigzag – myristoyl, red zigzag – palmitoyl residue. B: Jurkat cells expressing the indicated Csk constructs were ﬁxed,
permeabilized and stained with anti-Myc Ab followed by Alexa 488-labeled secondary Ab (yellow), nuclei were visualized with Hoechst (gray). C: Jurkat cells expressing CD25-Csk-
OFP, Thy1-TM25-Csk-OFP, CD7-Csk-OFP and LAT-Csk-OFP constructs were surface-stained on ice with FITC-labeled anti-Thy1 Ab, APC-labeled anti-CD25 Ab and anti-CD7. The
expression of the indicated Csk-OFP construct was analyzed by cytoﬂuorometry on live cells and is plotted against Thy1, CD25 and CD7.
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ultracentrifuge, using the MLS50 swing-out rotor (18 h, 50,000 rpm).
Nine 0.57 ml fractions were collected from top of the gradient and
mixed with SDS sample buffer, and proteins were separated by SDS-
PAGE and analyzed by immunoblotting.
2.5. Cell stimulation and cytoﬂuorometry
To measure upregulation of CD69, Jurkat cells were stimulated
overnight with C305 antibody (puriﬁed, 1 μg /ml), or left unstimu-
lated, cells were then washed with FACS buffer (PBS containing 2%
fetal calf serum (FCS) and 0.1% sodium azide) and stained on ice with
FITC-labeled anti-CD69 antibody. Alternatively, Raji B cells were
loaded with 0.1 μg/ml Staphylococcal enterotoxin E (SEE) and
incubated overnight with Jurkat cells at 1:1 ratio. To determine the
surface expression of CD25-Csk-OFP and Thy1-TM25-Csk-OFP, live
cells were similarly stained with antibodies speciﬁc for CD25 and
Thy1. To measure calcium response to anti-TCR activation, cells
expressing Csk chimeras fused with OFP were ﬁrst loaded with 5 μM
Fura-Red (Invitrogen) in loading buffer (1x Hanks balanced salt
solution, 2% FCS, without Ca2+, Mg2+) for 30 min at 37 °C. After
washing, cells were resuspended in loading buffer supplementedwith
Ca2+, Mg2+, and kept on ice. Before imaging calcium response, cells
were warmed for 10 min at 37 °C and then stimulated with C305mAb
(5 μg /ml). The treatment with AP21967 (0.5 μM) was carried out for
ﬁve min at 37 °C before stimulation with C305 Ab. The calcium
response was detected in a ratiometric setup using 405/480 nm
excitation. All ﬂow cytometry measurements were performed using
LSRII instrument (BD Biosciences). Analysis of the datawas performed
using the FlowJo software (Tree Star, Ashland, OR). To measure NFAT
activity, cells were ﬁrst electroporated using a GenePulser electro-
porator (Bio-Rad, Hercules, CA) with a reporter plasmid expressing
luciferase from an NFAT-responsive promoter, the luciferase activity
was then measured by adding the OneGlo substrate (Promega,
Madison, WI, USA) and the luminescence was assayed with the
EnVision reader. The TCR response was calculated as a % of maximal
response which was determined by stimulating the same cells with
PMA/Ionomycine.
2.6. Microscopy
Cells were washed with PBS and ﬁxed with 4% paraformaldehyde
for 15 min at room temperature and permeabilized with 0.1% Triton
X-100 for 5 min on ice. Cells were then incubated with anti-Myc
antibody followed with Alexa 488-labeled goat anti-mouse IgG
secondary antibody (Invitrogen), and nuclei were visualized with
Hoechst 33258 dye. Images were acquired on Leica SP5 confocal
microscope (Leica Microsystems, Wetzlar, Germany).
3. Results
3.1. Membrane and raft localization of the various csk constructs
To ﬁnd out how targeting Csk into different membrane compart-
ments inhibits TCR signaling, we prepared several C-terminally OFP-
tagged constructs containing distinct targeting motifs (Fig. 1A). To
minimize possible complicating effects of interactions of Csk SH2 and
SH3 domains with other proteins (regulatory enzymes, adaptors,
substrates), we used constitutively active Csk mutant (E154A), which
was further mutated to inactivate the SH2 (R107K mutation) and SH3
(W47A mutation) domains [26]. Some of the constructs were
designed for targeting into membrane rafts (Lck-Csk-OFP, Fyn-Csk-
OFP, LAT-Csk-OFP, LAT162-Csk-OFP, PAG-Csk-OFP), others to newly
described heavy raft-like microdomains [19] (LAX-Csk-OFP) or non-
raft membrane (CD25-Csk-OFP, Thy-1-TM25-Csk-OFP, Src-Csk-OFP,
CD7-Csk-OFP); cytoplasmic Csk-OFP served as a control. Theseconstructs were cloned into retroviral vector and were subsequently
used to create the respective Jurkat cell lines stably expressing these
constructs. Then, we veriﬁed by confocal microscopy (Fig. 1B) and
cytoﬂuorometry (in the cases of constructs possessing an extracellular
domain, Fig. 1C) that the constructs were properly expressed at the
plasma membrane. To characterize the membrane complexes con-
taining Csk constructs we ﬁrst performed gel ﬁltration analysis of the
membrane lysates on Sepharose 4B in the presence of mild lipid raft-
preserving detergent Brij-98. As shown in Fig. 2A, all the raft-targeted
constructs (LAT-Csk-OFP, Fyn-Csk-OFP, Lck- Csk-OFP, PAG- Csk-OFP)
were indeed present exclusively in large complexes, while the
presumably non-raft constructs (CD25-Csk-OFP, Src-Csk-OFP, Thy1-
TM25-Csk-OFP, CD7- Csk-OFP) were found mostly in low MW
fractions or displayed broader distribution clearly different from
lipid raft-targeted constructs. As expected from our previous work,
majority of the LAX-Csk-OFP construct was also present in a sort of
large DRMs apparently corresponding to the heavy raft-like micro-
domains [19]. A typical feature of classical lipid rafts, as well as heavy
raft-like microdomains, is their sensitivity to another mild detergent
laurylmaltoside (LM). The results of the gel ﬁltration experiment
which was performed in the presence of 1% LM (Fig. 2B) conﬁrmed,
that similarly to classical raft-targeted constructs, complexes contain-
ing LAX-Csk-OFP were disrupted in the presence of this detergent.
Next, to further conﬁrm proper targeting of our constructs, we
performed sucrose density gradient ultracentrifugation in the pres-
ence of 1% Brij-98 (Fig. 2C). The data demonstrate that targeting via
lipid raft-speciﬁc anchors (LAT-, Fyn-, Lck-, PAG-) led to an almost
exclusive partitioning of Csk to the low density fractions where the
classical lipid rafts are typically present. Importantly, none or
negligible amounts of the non-raft targeted Csk constructs could be
detected in the low density fractions, including the LAX-Csk-OFP
construct which was distributed very similarly to the previously
described heavy raft-targeted LAX-LAT-OFP construct. To rule out the
possibility that differential distribution of the LAT-Csk-OFP and LAX-
Csk-OFP constructs is a result of some general change in properties of
lipid rafts in the expressing cell lines, we determined the distribution
of the endogenous LAT protein in the cells expressing LAT-Csk-OFP,
LAX-Csk-OFP, CD25-Csk-OFP, and parental Jurkat cells and we did not
ﬁnd any signiﬁcant difference (Fig. 2D).We similarly tested remaining
Csk-expressing cell lines (data not shown) and found that LAT protein
was similarly distributed in all cell lines tested, conﬁrming, that
targeting Csk to lipid rafts does not perturb integrity of these
microdomains or the raft partitioning of endogenous LAT protein.
Collectively, our fractionation experiments conﬁrmed that the
insertions of the different membrane anchors target the Csk
constructs into various membrane compartments of different deter-
gent resistance (conventional rafts, heavy raft-like microdomains,
non-raft membranes).
3.2. Effects of the raft vs. Non-raft csk constructs on TCR signaling
Next we analyzed the effects of Csk membrane targeting on TCR-
mediated signaling. As shown in Fig. 3, the TCR-induced tyrosine
phosphorylation of cellular substrates was strongly inhibited in cells
expressing LAT-Csk-OFP, but not in those expressing LAX-Csk-OFP or
CD25-Csk-OFP. This ﬁnding indicates that only Csk targeted into
conventional membrane rafts is able to effectively inhibit TCR
signaling cascade by inactivating SFK necessary for the earliest steps.
In addition to the effects on tyrosine phosphorylation, we
determined the ability of the various Csk constructs to inhibit
cytoplasmic calcium elevations and CD69 upregulation following
TCR cross-linking. To ensure that we analyzed cells expressing equal
levels of the Csk-constructs, we compared cell populations of similar
OFP ﬂuorescence intensity. As shown in Fig. 4, the cells expressing
raft-targeted LAT-Csk-OFP poorly responded to TCR cross-linking as
measured by surface CD69 upregulation (Fig. 4A) and intracellular Ca
Fig. 2. Association of Csk constructs with (raft-like) detergent-resistant membrane complexes. A,B: Cells were homogenized to isolate cell membranes which were then solubilized
in the presence of 1% Brij-98 (A) or 1% LM (B) and subjected to gel ﬁltration on Sepharose 4B, Csk constructs were visualized by immunoblotting using anti-Myc Ab. C: Cells were
lysed in the presence of 1% Brij-98 and subjected to sucrose density gradient ultracentrifugation. The LAX-LAT-OFP construct was expressed in J.Cam2 cells as originally described
[18]. Constructs were visualized by immunoblotting using anti-Csk antibody. D: Distribution of endogenous LAT protein in the sucrose density gradient fractions prepared from the
indicated cell lines.
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cells expressing Csk targeted to the plasma membrane via other lipid-
raft speciﬁc anchors, such as TM domain of the adaptor protein PAG,
N-terminal double-acylated motif of kinases Lck and Fyn, and also
myristoylatedmotif of Src. In contrast, in cells expressing Csk tethered
to the membrane via non-raft anchors (CD25-Csk-OFP, CD7-Csk-OFP)
or the N-terminal motif of LAX (Linker for activation of X cells). TCR
signaling was minimally inhibited. The observation that all lipid-raft
speciﬁc anchors (i.e. those derived from LAT, PAG, Lck, Fyn) are
equally efﬁcient suggests that the possible heterogeneity among
various conventional membrane raft microdomains is not important,
at least for the functional interaction between Csk and the
SFK involved in the initiation of TCR signaling. The efﬁciency of theN-terminal motif of Src may be explained by its weak and/or transient
interaction with lipid rafts as discussed below.
Additionally, we tested the ability of the various Csk constructs to
inhibit Jurkat T cell activation following stimulation with SEE-pulsed
Raji B cells (Fig. 4C, D). The data in Fig. 4C demonstrate that
superantigen-pulsed Raji efﬁciently induced upregulation of CD69 in
Jurkat cells expressing non-raft LAX-Csk and CD25-Csk but we
observed minimal activation of cells expressing lipid-raft targeted
LAT-Csk and Lck-Csk constructs. Next, we determined the ability of
SEE-pulsed Raji cells to activate NFAT transcription factors (Fig. 4D) in
cells transfected with NFAT-luciferase reporter DNA plasmid. The data
show that lipid raft-targeted Csk efﬁciently inhibits NFAT-response
while non-raft targeted Csk does not. In summary, the presented data
Fig. 3. Inhibition of TCR-induced protein phosphorylation by raft-targeted Csk. Jurkat
cells expressing LAT-Csk-OFP, LAX-Csk-OFP, CD25-Csk-OFP and uninfected Jurkat were
activated with C305 Ab (5 μg /ml), or non-activated controls were lysed after indicated
time in SDS loading buffer, and phosphorylated proteins were separated by SDS PAGE/
immunoblotting and visualized with 4 G10 anti-pTyr Ab. Anti-GAPDH staining
demonstrates equal loading, anti-Myc staining shows the levels of expression of each
Csk construct.
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downstream events such as calcium response, CD69 upregulation,
tyrosine phosphorylation and NFAT activity following TCR activation
while non-raft Csk constructs fail to inhibit these events.
To demonstrate that the inhibition of TCR signaling is dependent
on Csk kinase activity, we generated another mutant, a kinase-dead
variant of LAT-Csk-OFP which contains inactivating K222R mutation
in the kinase domain in addition to the W47A, R107K, E154K
mutations introduced previously. The data in Fig. 5A show that Jurkat
cells expressing very high amounts of the kinase-dead LAT-Csk-OFP
construct efﬁciently upregulated CD69 following TCR stimulation
while cells expressing equally high amounts of the constitutively
active form of LAT-Csk-OFP construct completely failed to upregulate
CD69.
Next, we wanted to verify that the non-inhibiting constructs
possess comparable kinase activity to the raft targeted ones. To test
this, we co-transfected LAT-Csk-OFP, LAX-Csk-OFP, and CD25-Csk-
OFP constructs with kinase-inactive Lck as a substrate into 293 cells
and determined the level of tyrosine 505 phosphorylation in the
lysates by immunoblotting with pY505 speciﬁc antibody. In our
experience in this type of transient overexpression experiment the
concentration of the individual components is high enough to
overcome the need for speciﬁc targeting or compartmentalization
[27]. The results show comparable increase in Y505 phosphorylation
in all cells expressing active Csk irrespective of the type of the
targeting signal Fig. 5B, proving that the lack of inhibition of TCRFig. 4. Activation responses of Jurkat cells expressing various Csk constructs. A: The indica
cytoplasmic calcium response was measured, as described in Materials and methods. Cells
stimulated overnight with soluble C305 antibody (1 μg/ml), or left unstimulated. Surface e
numbers show the percentages of the CD69-positive cells out of total OFP+ cells. Control Jurk
cells were incubated overnight at 1:1 ratio with Raji B cells either pulsed with SEE (0.1 μg/m
values obtained after stimulation with unpulsed RAJI cells were subtracted from the values o
with NFAT-luciferase reporter plasmid and then stimulated similarly as in C, the maximumsignaling in cells expressing LAX-Csk-OFP and CD25-Csk-OFP is not
due to insufﬁcient catalytic activity of the Csk kinase domain.
It is well established that Csk inhibits SFK by promoting their
closed conformation via phosphorylation of their C-terminal tyrosine
(Y505 in human Lck). To test if the samemechanism is responsible for
the inhibition of TCR signaling in the cell lines used throughout our
study, we measured tyrosine phosphorylation of both inhibitory
tyrosine (Y505 in Lck) as well as activation loop tyrosine (Y394 in Lck,
Y416 in Src) by immunoblotting with site-directed phospho-speciﬁc
antibodies. Surprisingly, we have not seen any differences in the
phosphorylation of the SFK inhibitory tyrosine among the cell lines
tested while there was a clear reduction in phosphorylation of the
activation loop tyrosine in the LAT-CSK-OFP expressing cells as
compared to non-raft or heavy raft constructs (LAX-Csk-OFP, CD25-
Csk-OFP) (Fig. 6A). In order to better understand this surprising result,
we adopted an experimental system which enabled us to rapidly
recruit Csk to lipid rafts. It is based on inducible heterodimerization of
FKBP and FRB domains via a rapamycin analog AP21967 (Ariad
Pharmaceuticals). We have generated a Jurkat cell line stably
expressing FRB domain fused with LAT transmembrane domain.
This cell line was then transduced with retroviruses expressing Csk-
OFP fused at the C- terminus with a tandem FKBP domain, followed by
FACS puriﬁcation of transduced cells. The data in Fig. 6B show that the
addition of AP21967 led to the Csk membrane recruitment. Conse-
quently, 5 min pretreatment of cells with AP21967 signiﬁcantly
inhibited calcium response following C305 stimulation (Fig. 6C). The
duration of AP21967 pretreatment had no measurable effect on the
inhibition of TCR signaling, moreover, the calcium response could be
rapidly downregulated when AP21967 was added to the cells already
activated with anti-TCR antibody at the peak of calcium response
(data not shown). Thus, this experimental system allowed us to
analyze the phosphorylation status of Lck following rapid recruitment
of Csk to the membrane. The data in Fig. 6D show that following
addition of AP21967, the phosphorylation level of tyrosine 505 rapidly
increases but does not remain stable and within 30 min after addition
of AP21967 decreases to the levels present before addition of
AP21967. At the same time, the level of phosphorylation of the
activatory tyrosine 416 rapidly decreases and remains low. These data
suggest that Cskmembrane recruitment probably activates regulatory
feedback loops reducing overall SFK phosphorylation status, however,
these mechanisms do not seem to be able to revert the functional
inhibition imposed by Csk, since the ratio between inhibitory tyrosine
and activation loop phosphorylation remains largely preserved during
the process.
4. Discussion
Our present study employed differentially targeted Csk constructs
as tools to speciﬁcally inhibit Src-family kinases in different plasma
membrane subcompartments. We prepared a series of Csk constructs
tethered to plasma membrane by means of several motifs known to
target into different lipid microenvironments such as membrane rafts
(motifs derived from N-terminal sequences of typical raft proteins
such as Lck, Fyn, LAT, PAG), recently described heavy raft-like
microdomains (targeting sequence from transmembrane adaptor
LAX) [19] and non-raft membrane (constructs containing transmem-
brane domain from CD25). Since SH2 and SH3 domains are involved
in Csk targeting, we inactivated SH2 and SH3 domains in our
constructs by point mutations to prevent these domains fromted Jurkat cells were stimulated with C305 antibody (5 μg/ml) and dynamics of their
were gated on OFP+ similarly as in B. B: The indicated Jurkat cell transfectants were
xpression of the activation marker CD69 was then measured by cytoﬂuorometry. The
at cells which do not express any Csk construct are shown in the bottom panel. C: Jurkat
l) or non-pulsed, the response was then determined by staining with anti-CD69 Ab. The
btained after stimulation with SEE-pulsed RAJI cells. D: Jurkat cells were electroporated
response was determined after stimulation with PMA/Ionomycin.
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Fig. 5. Kinase activity of Csk. A: Jurkat cells expressing constitutively active LAT-Csk-OFP or kinase-dead LAT-Csk-OFP constructs were stimulated with anti-TCR antibody C305 and
then stained for the expression of activation marker CD69. B: 293 cells were co-transfected with kinase-inactive Lck mutant and indicated Csk constructs, or with Lck only. The
activity of Csk was determined by immunoblotting with pY505 speciﬁc antibody. Anti-Myc staining shows the level of expression of Csk constructs, anti-Lck shows the level of
expression of the substrate.
374 P. Otáhal et al. / Biochimica et Biophysica Acta 1813 (2011) 367–376overriding interactions mediated by the N-terminal motifs. However,
this approach created a potential problem, since binding of ligands to
the SH2/SH3 module is also important for activation of the Csk kinaseFig. 6. Phosphorylation of SFK in Jurkat cells expressing various Csk constructs. A: Jurkat cell
levels of pY505 and pY416were determined by immunoblotting with phospho-speciﬁc antib
typical experiment out of three performed which all gave similar results. B: Confocal ima
antibody (left panel). The same cells were treated with AP21967 (0.5 μM) for 30 min and loc
were pre-treated with AP21967 (0.5 μM) for 5 min and then the calcium response following
FLAG-FRB and Csk-OFP-FKBP were treated for the indicated time intervals with AP21967 (0.
three performed which all gave similar results.domain [26]. This is the reason why we also introduced an activating
mutation (E154A) to render the kinase sufﬁciently active even in the
absence of SH2/SH3 interactions [26].s expressing the indicated constructs were lysed and subjected to immunoblotting. The
odies followed by quantiﬁcationwith Odyssey infra-red scanner. The data represent one
ge of Jurkat cells expressing LAT-FLAG-FRB and CSK-OFP-FKBP stained with anti-Flag
alization of Csk-OFP-FKBP was then analyzed by confocal microscopy. C: The same cells
activation with anti-TCR antibody C305 was measured. D. Jurkat cells expressing LAT-
5 μM) and analyzed as described in A. The data represent one typical experiment out of
375P. Otáhal et al. / Biochimica et Biophysica Acta 1813 (2011) 367–376Our approach allowed us to compare relative importance of the
pools of endogenous SFK presumably present in different plasma
membrane subcompartments (classical raft, heavy raft, non-raft
membrane). Importantly, this approach is based on functional readouts
in intact cells, not on any detergent solubilization products, and is
directed to endogenous SFK. The most efﬁcient inhibition of TCR
signalingwas achievedwithCsk constructs targeted via anchors derived
from different membrane raft-associated molecules, while none of the
other constructs (with the exception of Src-Csk-OFP as discussed later)
were able to inhibit signaling as efﬁciently. This is an important and
highly relevant ﬁnding because of continuing discussions about the
nature or the very existence ofmembrane rafts [28–30]. It also identiﬁes
lipid rafts as a locationwhere themost efﬁcient regulation of SFK can be
achieved and warrants future research on membrane targeting of Csk
via lipid raft resident proteins such as PAG and LIMEwhich are in a very
good position to exert such regulation. This implies a transient nature of
PAG/LIME Csk interaction or an involvement of regulatory feedback
loops that our constructs could not elicit.
Our results are consistent with the idea of membrane rafts as
separated areas of the plasma membrane accessible only to a
restricted set of proteins possessing appropriate targeting motif.
Strikingly, all the membrane raft targeted Csk constructs exerted the
same level of inhibition independent of whether this motif was
derived from Lck, Fyn, LAT or PAG, suggesting that functional
heterogeneity within the membrane raft compartment is limited
and that perhaps any raft-targeted protein can in principle access any
of these structures. Recent data suggest that membrane rafts are very
small and dynamic structures containing probably very few protein
molecules [31,32]. Thus, the number of protein molecules per raft is
probably substantially lower than the overall number of protein
species accommodated in these structures globally, which implies
that at any given time point there will be a substantial heterogeneity
in the protein composition of these microdomains. However, since
there may be rapid exchange of proteins among individual rafts, this
heterogeneity might not be apparent on the time scale of our
experiments. Furthermore, it is likely that any rafts (of the classical
type, yielding upon detergent solubilization buoyant DRMs), regard-
less of their protein composition, may interact, due to their favorable
lipid composition, with TCR.
Surprisingly, we observed strong inhibition of TCR signaling when
the Csk construct targeted via N-terminal membrane targeting motif
of Src was used. We saw a relatively small but clearly detectable
fraction of Src-Csk-OFP in DRM-like large complexes sensitive to
laurylmaltoside extraction, suggesting that this construct may have an
access to membrane rafts (Fig. 2). However, we failed to detect any
Src-Csk-OFP in low density fractions after sucrose density ultracen-
trifugation. Data published on Src association with membrane rafts
have been rather controversial so far, with several studies supporting
this association and others failing to detect signiﬁcant Src presence in
these microdomains [33–36]. The presence of Src in membrane rafts
seemed to depend on its kinase activity and thus possibly on the
interaction of Src SH2 domain with some membrane raft resident
substrate such as PAG [37,38]. These data suggest that Src is not
excluded from membrane rafts, however, this interaction is probably
unstable and/or highly dynamic and its biochemical detection may
require stabilization by protein-protein interactions. If this is the case,
it may be difﬁcult to determine how large fraction of Src-Csk-OFP is
present in membrane rafts in vivo since this interaction may be prone
to disruption during the detergent extraction and lengthy fraction-
ation procedure, which is especially long when sucrose density
gradient centrifugation is employed. These data also suggest that
widely used non-raft speciﬁc membrane probes such as GFP anchored
to the membrane via N-terminal part of Src kinase [39] may in fact be
localized at least partially to the native membrane rafts.
Recently we described a novel type of raft-like microdomains,
detected as heavy DRMs, apparently also capable of certain functionalinteraction with TCR signaling [19]. Targeting to these microdomains
can be achieved via N-terminal membrane-anchoring segment of
transmembrane adaptor LAX. The present data conﬁrm and extend
our previous results on the functional difference between classical
rafts and the newly described heavy raft-like microdomains [19]. We
and others have shown that the LAX-LAT fusion protein targeted to
these microdomains is able to support TCR signal transduction albeit
less efﬁciently than LAT targeted to classical rafts [19,40]. In contrast,
the LAX-Csk construct (targeted to heavy rafts) used in this study was
not able to inhibit TCR signaling at all. By targeting the inhibitory
(Csk) rather than activatory (LAT) molecule to this compartment we
created an inverse situation to the previously used setting [19]. Our
present data indicate that heavy raft-like microdomains and non-raft
membrane most likely do not contain any pool of SFK that is critical
for initiation of TCR signal transduction.
Notable observations were made when we analyzed the mech-
anism of howmembrane-targeted Csk regulates SFK. Themajor effect
we observed after the long term expression of lipid raft-targeted Csk
was reduced phosphorylation of the tyrosine in the activation loop of
the SFK catalytic domain. Since this tyrosine is considered to be an
autophosphorylation site, reduced SFK activity should logically result
in reduced phosphorylation of this tyrosine. On the other hand it is
harder to explain why there was no change in the phosphorylation of
the C-terminal tyrosine which is the direct substrate of Csk. To better
understand this paradox, we employed a dimerizer system allowing
for rapid Csk recruitment to the plasma membrane, which helped us
to follow the dynamics of this process. We observed rapid initial
increase in the SFK inhibitory tyrosine phosphorylation soon after
Csk recruitment to lipid rafts. Phosphorylation peaked at 10 min and
then it returned back to the initial levels, while phosphorylation of
the activating tyrosine gradually declined throughout the experi-
ment. This observation suggested that Csk recruitment to lipid rafts
likely activates feedback mechanisms counterbalancing its inhibitory
effect. The reduction in SFK activity may for example result in
dephosphorylation of proteins recruiting endogenous Csk such as
PAG, LIME or Dok-family adaptors, which are all substrates of SFK
[5,7,41]. An alternative possibility is an active process involving
recruitment of a phosphatase to dephosphorylate SFK tyrosines.
However, regardless of the mechanism, such regulatory feedback is
not able to overcome the inhibition imposed by the lipid raft-
targeted Csk constructs.
Our present data are certainly compatible with the results
published recently by Lillemeier et al. [42] showing that after TCR
stimulation LAT complexes (i.e. membrane rafts) get into a close
contact with TCR microdomains but do not fuse with each other.
Although our data conﬁrm that membrane raft associated SFKs
play a critical role in TCR signaling, they do not directly address the
function of membrane rafts in this process. A widely discussed
possibility is that membrane rafts serve as a vehicle for translocation
of several critical signaling molecules to the TCR. However, at least for
LAT and Lck it has been recently shown that their cytoplasmic
domains are responsible for targeting to TCRmicroclusters apparently
independently of their presence in the membrane rafts [43]. Hence, it
seems that instead of being directly involved in the translocation
process, membrane rafts may be rather passively transported to the
proximity of TCR by the proteins they contain and may perhaps
inﬂuence the signaling by changing the protein and/or lipid
environment in the proximity of activated TCR. This hypothesis is
compatible with our present data, however, our model system cannot
be used to directly prove/disprove it. It simply shows, that only lipid
raft targeted Csk can efﬁciently inhibit SFKs in intact Jurkat cells,
demonstrating speciﬁc segregation of SFKs to membrane rafts in vivo.
This is a novel type of evidence for the existence of membrane rafts as
functional units in the plasma membrane of living cells, obtained
without any biochemical manipulations often criticized for their
proneness to artifact induction.
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